SCHEMBL8650550

SCHEMBL8650550

COC(=O)[C@@H](NC(=O)C(CCCc1ccc(Cl)cc1)CC(=O)O)C(C)(C)C

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 20/20 0.62
MMP3 P08254 10/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8663579 0.89 MMP2 (0.62) MMP2MMP3
SCHEMBL8655236 0.88 MMP2 (0.48) MMP2MMP3
SCHEMBL8652786 0.88 MMP2 (0.64) MMP2MMP3
SCHEMBL7784697 0.85 MMP2 (0.52) MMP2MMP3
SCHEMBL8650859 0.77 MMP2 (0.83) MMP2MMP3
SCHEMBL8665733 0.77 MMP2 (0.64) MMP2MMP3
SCHEMBL8665571 0.77 MMP2 (0.80) MMP2MMP3
SCHEMBL7762285 0.74 MMP2 (0.82) MMP2MMP3
SCHEMBL8650547 0.73 L3MBTL1 (0.40) MMP2MMP3
SCHEMBL9574068 0.73 MMP2 (0.57) MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0712390-B1 SUCCINAMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS GELATINASE AND COLLAGENASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 1998-12-09 EP disclosed
US-5827890-A ANGIOGENESIS INHIBITORS CELLTECH THERAPEUTICS LTD. (GB) 1998-10-27 US disclosed
WO-1995004033-A1 SUCCINAMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS GELATINASE AND COLLAGENASE INHIBITORS CELLTECH LIMITED (GB) 1995-02-09 WO disclosed